alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# L_2006226EN.01001001.xml

| 18.8.2006 | EN | Official Journal of the European Union | L 226/10 |
| --- | --- | --- | --- |

18.8.2006

EN

Official Journal of the European Union

L 226/10

---

COMMISSION REGULATION (EC) No 1244/2006

of 17 August 2006

amending the rates of refunds applicable to certain products from the sugar sector exported in the form of goods not covered by Annex I to the Treaty

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EC) No 318/2006 of 20 February 2006 on the common organisation of the market in the sugar sector (1), and in particular Article 33(2)(a) and (4) thereof,

Whereas:

| (1) | The rates of the refunds applicable from 28 July 2006 to the products listed in the Annex, exported in the form of goods not covered by Annex I to the Treaty, were fixed by Commission Regulation (EC) No 1151/2006 (2). |
| --- | --- |

(1)

The rates of the refunds applicable from 28 July 2006 to the products listed in the Annex, exported in the form of goods not covered by Annex I to the Treaty, were fixed by Commission Regulation (EC) No 1151/2006 (2).

| (2) | It follows from applying the rules and criteria contained in Regulation (EC) No 1151/2006 to the information at present available to the Commission that the export refunds at present applicable should be altered as shown in the Annex hereto, |
| --- | --- |

(2)

It follows from applying the rules and criteria contained in Regulation (EC) No 1151/2006 to the information at present available to the Commission that the export refunds at present applicable should be altered as shown in the Annex hereto,

HAS ADOPTED THIS REGULATION:

Article 1

The rates of refund fixed by Regulation (EC) No 1151/2006 are hereby altered as shown in the Annex hereto.

Article 2

This Regulation shall enter into force on 18 August 2006.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 17 August 2006.

For the Commission

Günter VERHEUGEN

Vice-President

---

(1)  
  OJ L 58, 28.2.2006, p. 1.

1

(2)  
  OJ L 207, 28.7.2006, p. 23.

2

---

ANNEX

Rates of refunds applicable from 18 August 2006 to certain products from the sugar sector exported in the form of goods not covered by Annex I to the Treaty (1)

| CN code | Description | Rate of refund in EUR/100 kg |
| --- | --- | --- |
| In case of advance fixing of refunds | Other |
| 1701 99 10 | White sugar | 30,96 | 30,96 |

CN code

Description

Rate of refund in EUR/100 kg

In case of advance fixing of refunds

Other

1701 99 10

White sugar

30,96

30,96

---

(1)  The rates set out in this Annex are not applicable to exports to Bulgaria, with effect from 1 October 2004, to Romania with effect from 1 December 2005, and to the goods listed in Tables I and II to Protocol No 2 to the Agreement between the European Community and the Swiss Confederation of 22 July 1972 exported to the Swiss Confederation or to the Principality of Liechtenstein with effect from 1 February 2005.

---
# L_2013135DE.01002301.xml

| 22.5.2013 | DE | Amtsblatt der Europäischen Union | L 135/23 |
| --- | --- | --- | --- |

22.5.2013

DE

Amtsblatt der Europäischen Union

L 135/23

---

Berichtigung der Verordnung (EG) Nr. 1932/2006 des Rates vom 21. Dezember 2006 zur Änderung der Verordnung (EG) Nr. 539/2001 zur Aufstellung der Liste der Drittländer, deren Staatsangehörige beim Überschreiten der Außengrenzen im Besitz eines Visums sein müssen, sowie der Liste der Drittländer, deren Staatsangehörige von dieser Visumpflicht befreit sind

(
  Amtsblatt der Europäischen Union L 405 vom 30. Dezember 2006
  )

Amtsblatt der Europäischen Union L 405 vom 30. Dezember 2006

(Berichtigte Fassung im
  ABl. L 29 vom 3.2.2007, S. 10
  )

ABl. L 29 vom 3.2.2007, S. 10

Die nachstehenden Bezugnahmen beziehen sich auf die Veröffentlichung im ABl. L 29 vom 3.2.2007, S. 10:

Seite 12, Artikel 1 Nummer 5 Buchstabe a Ziffer ii:

anstatt:

| „ii) | folgende Länderbezeichnungen werden eingefügt:
  ‚Antigua und Barbuda (*)
  Bahamas (*)
  Barbados (*)
  Mauritius (*)
  Seychellen (*)‘;“ |
| --- | --- |

„ii)

folgende Länderbezeichnungen werden eingefügt:

‚Antigua und Barbuda (*)

Bahamas (*)

Barbados (*)

Mauritius (*)

Seychellen (*)‘;“

muss es heißen:

| „ii) | folgende Länderbezeichnungen werden eingefügt:
  ‚Antigua und Barbuda (*)
  Bahamas (*)
  Barbados (*)
  Mauritius (*)
  St. Kitts und Nevis (*)
  Seychellen (*)‘;“. |
| --- | --- |

„ii)

folgende Länderbezeichnungen werden eingefügt:

‚Antigua und Barbuda (*)

Bahamas (*)

Barbados (*)

Mauritius (*)

St. Kitts und Nevis (*)

Seychellen (*)‘;“.

---
#### Keith DeWayne JOHNSON, a/k/a Keith Muse, Appellant, v. The STATE of Oklahoma, Appellee.

No. F-85-704.

Court of Criminal Appeals of Oklahoma.

Feb. 24, 1988.

*197Terry J. Hull, Asst. Appellate Public Defender, Norman, for appellant.

Robert H. Henry, Atty. Gen., M. Caroline Emerson, Asst. Atty. Gen., Oklahoma City, for appellee.

OPINION

BUSSEY, Judge:

The appellant, Keith DeWayne Johnson, was tried and convicted in the District Court of Jackson County of the crimes of Assault With a Dangerous Weapon After Former Conviction of a Felony (Count I), and Feloniously Carrying a Firearm (Count II) and was sentenced to twelve (12) years imprisonment on Count I and four (4) years imprisonment on Count II, the sentences to run consecutively, and he appeals.

Briefly stated, the facts are that on the morning of August 25, 1984, appellant went to his girlfriend’s grandmother’s house where he threatened his girlfriend with a .25 caliber automatic pistol, pointed the pistol at her, fired the pistol twice over his shoulder as he forced her into his car, and assaulted her with his fists.

In his first assignment of error, appellant contends that his sentence is excessive and was imposed due to improper prosecutorial comments. However, since appellant failed to object to any of the alleged erroneous comments, all error has been waived except that of a fundamental nature. *Raymond v. State,*717 P.2d 1147 (Okl.Cr.1986). We find that none of the remarks was of such a nature that it could not have been cured had appellant objected and requested the trial court to admonish the jury. Therefore, we decline to modify appellant’s sentence. This assignment is groundless.

Appellant next alleges that the jury was improperly and deliberately exposed to other crimes evidence in the guilt stage of trial when one of the witnesses testified that he observed appellant shoot at his uncle with a small automatic pistol just a few minutes prior to the time that appellant assaulted his girlfriend. We disagree. This Court has held that evidence of other crimes may be admitted to show the character of the offense charged when the offenses are so proximate to one another in time and space as to form part of the entire transaction. *Wahid v. State,*716 P.2d 678 (Okl.Cr.1986), cert. denied 476 U.S. 1173, 106 S.Ct. 2899, 90 L.Ed.2d 985. In the present case, we are of the opinion that the evidence that appellant shot at his uncle with a small automatic pistol minutes before shooting at his girlfriend was properly admitted as part of the entire transaction. Furthermore, evidence that appellant, a convicted felon, was in possession of a firearm at his uncle’s house was relevant evi*198dence regarding appellant’s possession of a firearm which is an element of the offense of Feloniously Carrying a Firearm. This contention is accordingly denied.

The judgments and sentences are AFFIRMED.

BRETT, P.J., and PARKS, J., concur.
Exhibit 32



CERTIFICATION  PURSUANT TO THE SARBANES-OXLEY ACT

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002



I, Vincent Verdiramo, President of Serino 3, Corp. (the Company) do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



1.  This Quarterly Report on Form 10-QSB of the Company for the period ended October 31, 2005 as filed with the Securities and Exchange Commission (the report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.  The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  December 14, 2005

/s/ Vincent L. Verdiramo

___________________________



President
EXHIBIT 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Triple Crown Media, Inc. (the Company) on Form 10-Q for the fiscal quarterly period ended March 31, 2007 as filed with
the Securities and Exchange Commission on the date therein specified (the Report), the undersigned Chief Executive Officer of the Company, certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of his individual knowledge and belief:



|(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------



|(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: May 14, 2007



|        |  |                                      
|------- |  | -------------------------------------
|        | 
|Signed: |  | /s/ THOMAS J. STULTZ                 
|        |  | Thomas J. Stultz                     
|        |  | President and Chief Executive Officer

The foregoing certification is being furnished pursuant to 18 U.S.C. Section 1350. It is not being filed for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, regardless of any general incorporation language in said filing.
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER

Appellate case name: In the Interest of O.J.P., a Child

Appellate case number: 01-21-00163-CV

Trial court case number: 2016-25857

Trial court: 246th District Court of Harris County

This is an accelerated appeal from an order terminating the parental rights of appellant, 

C.D.P. This Court is required to bring the appeal to final disposition within 180 days of March 

29, 2021, the date the first notice of appeal was filed, so far as reasonably possible. See TEX. R.

JUD. ADMIN. 6.2, reprinted in TEX. GOV’T CODE ANN., tit. 2, subtit. F app.

Appellant’s brief was originally due on May 10, 2021. See TEX. R. APP. P. 38.6(a). 

Appellant has filed three motions for extensions of time, which we have granted. See TEX. R. APP.

P. 38.6(a), (d). After granting appellant’s third motion for extension of time, this Court extended

the deadline for filing appellant’s brief to July 14, 2021—sixty-five days past the original due 

date—with no further extensions. Appellant has not filed a brief.

Appellant’s brief is due NO LATER THAN JULY 23, 2021. No extensions will be 

granted. If appellant does not file a brief as directed, we may abate this appeal and remand 

the case to the trial court to determine whether appellant wishes to pursue her appeal and 

whether substitute counsel should be appointed to represent appellant on appeal.

It is so ORDERED.

Judge’s signature: /s/Julie Countiss

Acting individually 

Date: July 15, 2021
[Federal Register Volume 77, Number 48 (Monday, March 12, 2012)]
[Notices]
[Page 14533]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-5932]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel; ``BRAD''.
    Date: March 30, 2012.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6100 Executive Boulevard, 
Rockville, MD 20852.
    Contact Person: Sherry L. Dupere, Ph.D., Director, Division of 
Scientific Review, Division of Scientific Review, Eunice Kennedy 
Shriver National Institute of Child Health and Human Development, 
NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, 301-451-
3415, <a href="/cdn-cgi/l/email-protection#7317060316011600331e121a1f5d1d1a1b5d141c05"><span class="__cf_email__" data-cfemail="c5a1b0b5a0b7a0b685a8a4aca9ebabacadeba2aab3">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: March 2, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-5932 Filed 3-9-12; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### In the Matter of Kevin J. Delahunty, Appellant, v *213Board of Trustees of the New York City Fire Department et al., Respondents.

Judgment, Supreme Court, New York County (Leonard Cohen, J.), entered April 26, 1990, which denied and dismissed the CPLR article 78 petition seeking to vacate and annul respondent Board of Trustees of the New York City Fire Department’s determination granting petitioner ordinary disability retirement benefits and denying him accident disability retirement, unanimously affirmed, without costs.

Petitioner argues the Medical Board’s failure to set forth the basis for its finding that petitioner’s disabling condition is unrelated to a line of duty automobile accident renders the Board of Trustees’ reliance thereon "without foundation”, and thus arbitrary and capricious. However, respondent’s determination expressly relied upon medical evidence showing petitioner was disabled by a degenerative disease of the lower back.

Petitioner’s further claim that the automobile accident aggravated a dormant or asymptomatic lumbar condition, resulting in his disability *(see generally, Matter of Tobin v Steisel,*64 NY2d 254), is unsubstantiated by medical opinion. Petitioner, as an applicant for accident disability benefits, has the burden of establishing that disability is causally related to a line of duty accident *(Matter of Drayson v Board of Trustees,*37 AD2d 378, *affd*32 NY2d 852). The medical report of petitioner’s own physician nowhere states that the automobile accident aggravated a pre-existing lumbar condition. Indeed, petitioner’s physician made no mention whatsoever of petitioner’s degenerative disc disease, but rather, opined that petitioner’s disability was the direct and proximate result of the automobile accident. Where, as here, a conflict in medical opinion exists, the Trustees are entitled to rely on the report and recommendation of the Medical Board *(Matter of Drayson v Board of Trustees, supra).*Further, the record indicates both the Medical Board and Board of Trustees considered petitioner’s aggravation argument and rejected it based upon a review of the medical evidence presented *(cf., Matter of Meyer v McGuire,*64 NY2d 1152). Concur—Carro, J. P., Milonas, Asch, Kassal and Rubin, JJ.
**Exhibit 31.2****CERTIFICATION**     I, Robert J. Cox, certify that:     (1) I have reviewed this Quarterly Report on Form 10-Q of DealerTrack Holdings, Inc.;     (2) Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report;     (3) Based on my knowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in this report;     (4) The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:     (a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others withinthose entities, particularly during the period in which this report is being prepared;     (b) Designed such internal control over financial reporting, or caused such internal controlover financial reporting to be designed under our supervision, to provide reasonable assuranceregarding the reliability of financial reporting and the preparation of financial statements forexternal purposes in accordance with generally accepted accounting principles;     (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures as of the end of the period covered by this report based on such evaluation; and     (d) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and     (5) The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors:     (a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financial information; and     (b) Any fraud, whether or not material, that involves management or other employees who havea significant role in the registrant’s internal control over financial reporting.        /s/ Robert J. Cox III   Robert J. Cox III   Senior Vice President, Chief Financial Officer
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF

THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Chelsea Therapeutics International, Ltd. (the
Company) for the period ended June 30, 2006 as filed with the Securities and Exchange Commission on or about the date hereof (the Report), I, Simon Pedder, President and Chief Executive Officer, hereby certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods
presented in the Report.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



/s/ Simon PedderSimon PedderPresident and Chief Executive OfficerAugust 10, 2006
II 

111TH CONGRESS 

1ST SESSION S. 2009 

To extend temporarily the suspension of duty on 3,3′,4,4′- 

Biphenyltetracarboxylic dianhydride. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 28, 2009 

Mr. CHAMBLISS introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To extend temporarily the suspension of duty on 3,3′,4,4′- 

Biphenyltetracarboxylic dianhydride. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. 3,3′,4,4′-BIPHENYLTETRACARBOXYLIC 

4 DIANHYDRIDE. 

5 (a) IN GENERAL.—Heading 9902.05.11 of the Har6 monized Tariff Schedule of the United States (relating to 

7 3,3′,4,4′-Biphenyltetracarboxylic dianhydride) is amended 

8 by striking ‘‘12/31/2009’’ and inserting ‘‘12/31/2011’’. 

9 (b) EFFECTIVE DATE.—The amendment made by 

10 subsection (a) applies to goods entered, or withdrawn from 


smartinez on DSKB9S0YB1PROD with BILLS
2 

•S 2009 IS

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


smartinez on DSKB9S0YB1PROD with BILLS